These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17251285)

  • 1. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes.
    Honeyborne I; Prendergast A; Pereyra F; Leslie A; Crawford H; Payne R; Reddy S; Bishop K; Moodley E; Nair K; van der Stok M; McCarthy N; Rousseau CM; Addo M; Mullins JI; Brander C; Kiepiela P; Walker BD; Goulder PJ
    J Virol; 2007 Apr; 81(7):3667-72. PubMed ID: 17251285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
    Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ
    J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.
    Vali B; Tohn R; Cohen MJ; Sakhdari A; Sheth PM; Yue FY; Wong D; Kovacs C; Kaul R; Ostrowski MA
    J Virol; 2011 Jan; 85(1):254-63. PubMed ID: 20980521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
    Bailey JR; Williams TM; Siliciano RF; Blankson JN
    J Exp Med; 2006 May; 203(5):1357-69. PubMed ID: 16682496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
    Geels MJ; Dubey SA; Anderson K; Baan E; Bakker M; Pollakis G; Paxton WA; Shiver JW; Goudsmit J
    J Virol; 2005 Sep; 79(17):11247-58. PubMed ID: 16103177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure.
    Ngumbela KC; Day CL; Mncube Z; Nair K; Ramduth D; Thobakgale C; Moodley E; Reddy S; de Pierres C; Mkhwanazi N; Bishop K; van der Stok M; Ismail N; Honeyborne I; Crawford H; Kavanagh DG; Rousseau C; Nickle D; Mullins J; Heckerman D; Korber B; Coovadia H; Kiepiela P; Goulder PJ; Walker BD
    AIDS Res Hum Retroviruses; 2008 Jan; 24(1):72-82. PubMed ID: 18275350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
    Geldmacher C; Currier JR; Herrmann E; Haule A; Kuta E; McCutchan F; Njovu L; Geis S; Hoffmann O; Maboko L; Williamson C; Birx D; Meyerhans A; Cox J; Hoelscher M
    J Virol; 2007 Mar; 81(5):2440-8. PubMed ID: 17182686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
    Matthews PC; Koyanagi M; Kløverpris HN; Harndahl M; Stryhn A; Akahoshi T; Gatanaga H; Oka S; Juarez Molina C; Valenzuela Ponce H; Avila Rios S; Cole D; Carlson J; Payne RP; Ogwu A; Bere A; Ndung'u T; Gounder K; Chen F; Riddell L; Luzzi G; Shapiro R; Brander C; Walker B; Sewell AK; Reyes Teran G; Heckerman D; Hunter E; Buus S; Takiguchi M; Goulder PJ
    J Virol; 2012 Dec; 86(23):12643-54. PubMed ID: 22973023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.
    Kloverpris HN; Stryhn A; Harndahl M; van der Stok M; Payne RP; Matthews PC; Chen F; Riddell L; Walker BD; Ndung'u T; Buus S; Goulder P
    J Virol; 2012 Jan; 86(2):919-29. PubMed ID: 22090105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Design of Epitope-Enriched HIV-1 Gag Antigens with Preserved Structure and Function for Induction of Broad CD8
    Asbach B; Meier JP; Pfeifer M; Köstler J; Wagner R
    Sci Rep; 2018 Jul; 8(1):11264. PubMed ID: 30050069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.
    Semeniuk CA; McKinnon L; Peters HO; Gubbins M; Mao X; Ball TB; Luo M; Plummer FA
    AIDS; 2009 Apr; 23(7):771-7. PubMed ID: 19287301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
    López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of HIV-1 to human leukocyte antigen class I.
    Kawashima Y; Pfafferott K; Frater J; Matthews P; Payne R; Addo M; Gatanaga H; Fujiwara M; Hachiya A; Koizumi H; Kuse N; Oka S; Duda A; Prendergast A; Crawford H; Leslie A; Brumme Z; Brumme C; Allen T; Brander C; Kaslow R; Tang J; Hunter E; Allen S; Mulenga J; Branch S; Roach T; John M; Mallal S; Ogwu A; Shapiro R; Prado JG; Fidler S; Weber J; Pybus OG; Klenerman P; Ndung'u T; Phillips R; Heckerman D; Harrigan PR; Walker BD; Takiguchi M; Goulder P
    Nature; 2009 Apr; 458(7238):641-5. PubMed ID: 19242411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele.
    Roider J; Kalteis AL; Vollbrecht T; Gloning L; Stirner R; Henrich N; Bogner JR; Draenert R
    PLoS One; 2013; 8(12):e80045. PubMed ID: 24312453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
    Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality.
    Mkhwanazi N; Thobakgale CF; van der Stok M; Reddy S; Mncube Z; Chonco F; Walker BD; Altfeld M; Goulder PJ; Ndung'u T
    Virology; 2010 Sep; 405(2):483-91. PubMed ID: 20638093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.